
The Food and Drug Administration has approved a company’s application to register ivermectin as an anti-nematode drug, the government agency announced Friday.
Nematodes are also known as roundworms.
FDA Director General Eric Domingo confirmed that a certain company — Lloyd Laboratories — previously applied for a Certificate of Product Registration for domestically-manufactured ivermectin as an anti-nematode drug.
“It was granted after they submitted data to support quality and stability of the product,” said Domingo.
The company is one of two local pharmaceutical firms which previously expressed their intention to register with the FDA for ivermectin production. Reports say that the other company is Pascual Laboratories Inc.
Ivermectin is still not registered in the Philippines for treatment or prevention of COVID-19. Six hospitals were earlier given compassionate special permits by the FDA to administer the anti-parasitic drug to COVID-19 patients.